Skip to main content
SpringerLink
Log in

Pharmacological Treatment of Non-suicidal Self-injury and Eating Disorders

  • Chapter
  • First Online:
Non-Suicidal Self-Injury in Eating Disorders

Abstract

There is very little evidence for the psychopharmacological treatment of NSSI and eating disorders and no evidence for the treatment of a combination of both. However, often patients with NSSI and eating disorders present with comparable problems with regard to emotional dysregulation, the need to control urges (e.g., to cut or to binge or purge), and the need to treat comorbid mental disorders or psychiatric symptoms such as depression or anxiety. Based on the recent literature, this chapter aims to summarize the available literature and give recommendations for the psychopharmacological treatment of these conditions. Due to the limited evidence that is available for this kind of treatment, we strongly recommend to use psychopharmacological treatment only in addition to psychotherapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 84.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AA:

Atypical antipsychotics

BPD:

Borderline personality disorder

CBT:

Cognitive behavioral therapy

DBT:

Dialectical behavioral therapy

NDD:

Neurodevelopmental disorders

NSSI:

Non-suicidal self-injury

OCD:

Obsessive-compulsive disorder

PDD:

Pervasive developmental disorder

PRN:

“Pro re nata” medication

RCT:

Randomized controlled trial

SSRI:

Selective serotonin reuptake inhibitor

TCA:

Tricyclic antidepressant

References

  • Abraham, P. F., & Calabrese, J. R. (2008). Evidence-based pharmacologic treatment of borderline personality disorder: A shift from SSRIs to anticonvulsants and atypical antipsychotics? Journal of Affective Disorders, 111, 21–30.

    Article  CAS  PubMed  Google Scholar 

  • Aigner, M., Treasure, J., Kaye, W., Kasper, S., & WFSBP Task Force On Eating Disorders. (2011). World ion of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World Journal of Biological Psychiatry, 12, 400–443.

    Article  PubMed  Google Scholar 

  • Attia, E., & Schroeder, L. (2005). Pharmacologic treatment of anorexia nervosa: Where do we go from here? International Journal of Eating Disorders, 37, S60–S63.

    Article  PubMed  Google Scholar 

  • Bellino, S., Paradiso, E., & Bogetto, F. (2005). Oxcarbazepine in the treatment of borderline personality disorder: A pilot study. Journal of Clinical Psychiatry, 66, 1111–1115.

    Article  CAS  PubMed  Google Scholar 

  • Bloom, C. M., & Holly, S. (2011). Toward new avenues in the treatment of nonsuicidal self-injury. Journal Pharmacy Practice, 24, 472–477.

    Article  Google Scholar 

  • Brent, D. A. (2004). Antidepressants and pediatric depression—The risk of doing nothing. New England Journal of Medicine, 351, 1598–1601.

    Article  CAS  PubMed  Google Scholar 

  • Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L., et al. (2009). Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. American Journal of Psychiatry, 166, 418–426.

    Article  PubMed  Google Scholar 

  • Brent, D. A., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioural therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association, 299, 901–913.

    Article  CAS  PubMed  Google Scholar 

  • Burgess, S., Geddes, J., Hawton, K., Townsend, E., Jamison, K., & Goodwin, G. (2001). Lithium for maintenance treatment of mood disorders. Cochrane Database of Systematic Reviews, 3, CD003013.

    PubMed  Google Scholar 

  • Cassano, P., Lattanzi, L., Pini, S., Dell’Osso, L., Battistini, G., & Cassano, G. B. (2001). Topiramate for self-mutilation in a patient with borderline personality disorder. Bipolar Disorders, 3, 161.

    Article  CAS  PubMed  Google Scholar 

  • Chengappa, K. N. R., Ebeling, T., Kang, J. S., Levine, J., & Parepally, H. (1999). Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry, 60, 477–484.

    Article  CAS  PubMed  Google Scholar 

  • Cipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005). Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. American Journal of Psychiatry, 162, 1805–1819.

    Article  PubMed  Google Scholar 

  • Claudino, A. M., Slva de Lima, M., Hay, P. P. J., Bacaltchuk, J., Schmidt, U. U. S., & Treasure, J. (2009). Antidepressants for anorexia nervosa (review). The Cochrane Library, 1, 1–47.

    Google Scholar 

  • Cordàs, T. A., Tavares, H., Calderoni, D. M., Stump, G. V., & Ribeiro, R. B. (2006). Oxcarbazepine for self-mutilating bulimic patients. International Journal of Neuropsychopharmacology, 9, 769–771.

    Article  PubMed  Google Scholar 

  • Correll, C. U. (2007). Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short term trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 687–700.

    Article  PubMed  Google Scholar 

  • Corwin, R. L., Boan, J., Peters, K. F., & Ulbrecht, J. S. (2012). Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study. Behavioral Pharmacology, 23, 616–625.

    Article  CAS  Google Scholar 

  • Cowdry, R. W., & Gardner, D. L. (1988). Pharmacotherapy for borderline personality disorder. Archives of General Psychiatry, 45, 111–119.

    Article  CAS  PubMed  Google Scholar 

  • de la Fuente, J. M., & Lotstra, F. (1994). A trial of carbamazepine in borderline personality disorder. European Neuropsychopharmacol, 4, 479–486.

    Article  Google Scholar 

  • Dickstein, D. P., Towbin, K. E., Van Der Veen, J. W., Rich, B. A., Brotman, M. A., Knopf, L., et al. (2009). Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation. Journal of Child and Adolescent Psychopharmacology, 19, 61–73.

    Article  PubMed  Google Scholar 

  • Donovan, S., Clayton, A., Beeharry, M., Jones, S., Kirk, C., Waters, K., et al. (2000). Deliberate self-harm following antidepressant drugs. British Journal of Psychiatry, 177, 551–556.

    Article  CAS  PubMed  Google Scholar 

  • Faris, P. L., Kim, S. W., Meller, W. H., Goodale, R. L., Oakman, S. A., Hofbauer, R. D., Marshall, A. M., Daughters, R. S., Banerjee-Stevens, D., Eckert, E. D., & Hartman, B. K. (2000). Effect of decreasing afferent vagal activity with Ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial. Lancet, 355, 792–797.

    Article  CAS  PubMed  Google Scholar 

  • Fassino, S., Leombruni, P., Daga, G., Brustolin, A., Migliaretti, G., Cavallo, F., & Rovera, G. (2002). Efficacy of citalopram in anorexia nervosa: A pilot study. European Neuropsychopharmacology, 12, 453–459.

    Article  CAS  PubMed  Google Scholar 

  • Flament, M. F., Bissada, H., & Spettigue, W. (2012). Evidence-based pharmacotherapy of eating disorders. International Journal of Neuropsychopharmacology, 15, 189–207.

    Article  CAS  PubMed  Google Scholar 

  • Forbes, D., & Pearsons, H. (2012). Essential fatty acids: Food for mind and body. Acta Paediatrica, 101, 806–810.

    Article  Google Scholar 

  • Garland, M. R., Hallahan, B., McNamara, M., Carney, P. A., Grimes, H., Hibbeln, J. R., et al. (2007). Lipids and essential fatty acids in patients presenting with self-harm. British Journal of Psychiatry, 190, 112–117.

    Article  PubMed  Google Scholar 

  • Gibbons, R. D., Brown, H., Hur, K., Davis, J. M., & Mann, J. J. (2012). Suicidal thoughts and behaviour with antidepressant treatment. Archives of General Psychiatry, 69, 580–587.

    Article  CAS  PubMed  Google Scholar 

  • Good, C. R. (2006). Adjunctive Quetiapine targets self-harm behaviors in adolescent females with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 16, 235–236.

    Article  CAS  PubMed  Google Scholar 

  • Goodyer, I., Dubicka, B., Wilkinson, P., Kelvin, R., Roberts, C., Byford, S., et al. (2007). Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: Randomised controlled trial. British Medical Journal, 335, 142–150.

    Article  CAS  PubMed  Google Scholar 

  • Greetfeld, M., Cuntz, U., & Vorderholzer, U. (2012). Pharmacotherapy for anorexia nervosa and bulimia nervosa. Fortschritte Der Neurologie Psychiatrie, 80, 9–16.

    Article  CAS  PubMed  Google Scholar 

  • Griengl, H., Sendera, A., & Dantendorfer, K. (2001). Naltrexone as a treatment of self-injurious behavior: A case report. Acta Psychiatrica Scandinavica, 103, 234–236.

    Article  CAS  PubMed  Google Scholar 

  • Grootens, K. P., & Verkes, R. J. (2005). Emerging evidence for the use of atypical antipsychotics in borderline personality disorder. Pharmacopsychiatry, 38, 20–23.

    Article  CAS  PubMed  Google Scholar 

  • Groschwitz, R. C., & Plener, P. L. (2012). The neurobiology of non-suicidal self-injury (NSSI): A review. Suicidology Online, 3, 24–32.

    Google Scholar 

  • Haleem, D. J. (2012). Serotonin neurotransmission in anorexia nervosa. Behavioural Pharmacology, 23, 478–495.

    Article  CAS  PubMed  Google Scholar 

  • Hallahan, B., Hibbeln, J. R., Davis, J. M., & Garland, M. R. (2007). Omega-3 fatty acid supplementation in patients with recurrent self-harm. British Journal of Psychiatry, 190, 118–122.

    Article  PubMed  Google Scholar 

  • Harper, G. (2012). Psychopharmacological treatment. In B. W. Walsh (Ed.), Treating self-injury. A practical guide (2nd ed., pp. 195–203). New York: The Guilford Press.

    Google Scholar 

  • Hawton, K., Townsend, E., Arensmann, E., Gunnel, D., Hazell, P., House, A., & van Heeringen, K. (2009). Psychosocial and pharmacological treatments for deliberate self harm. Cochrane Database of Systematic Reviews, 1999(4). Art. No.: CD001764. doi:10.1002/14651858.CD001764.

  • Herpertz, S., Hagenah, U., Vocks, S., von Wietersheim, J., Cuntz, U., & Zeeck, A. (2011). Clinical practice guideline: The diagnosis and treatment of eating disorders. Deutsches Ärzteblatt International, 108, 678–685.

    PubMed  Google Scholar 

  • Hilger, E., Barnas, C., & Kasper, S. (2003). Quetiapine in the treatment of borderline personality disorder. World Journal Biological Psychiatry, 4, 42–44.

    Article  Google Scholar 

  • Holtkamp, K., Konrad, K., Kaiser, N., Ploenes, Y., Heussen, N., Grzella, I., & Herpertz-Dahlmann, B. (2005). A retrospective study of SSRI treatment in adolescent anorexia nervosa: Insufficient evidence for efficacy. Journal of Psychiatric Research, 39, 303–310.

    Article  CAS  PubMed  Google Scholar 

  • Ingenhoven, T., Lafay, P., Rinne, T., Passchierj, J., & Duivenvoorden, H. (2010). Effectiveness of pharmacotherapy for severe personality disorders: Meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry, 71, 14–25.

    Article  CAS  PubMed  Google Scholar 

  • Isacsson, J., Holmgren, P., & Ahlner, J. (2005). Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: A controlled forensic database study of 14 857 suicides. Acta Psychiatrica Scandinavica, 111, 286–290.

    Article  CAS  PubMed  Google Scholar 

  • Katz, L. Y., & Fotti, S. (2005). The role of behavioral analysis in the pharmacotherapy of emotionally-dysregulated problem behaviors. Child and Adolescent Psychopharmacology News, 10, 1–5.

    Article  Google Scholar 

  • Kaye, W. H., Frank, G. K., Bailer, U. F., & Henry, S. E. (2005). Neurobiology of anorexia nervosa: Clinical implications of alterations of the function of serotonin and other neuronal systems. International Journal of Eating Disorders, 37, S15–S19.

    Article  PubMed  Google Scholar 

  • Kaye, W. H., Gendall, K., & Strober, M. (1998). Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biological Psychiatry, 44, 825–838.

    Article  CAS  PubMed  Google Scholar 

  • Kishi, T., Kafantaris, V., Sunday, S., Sheridan, E. M., & Correll, C. U. (2012). Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. Journal of Clinical Psychiatry, 73, e757–e766.

    Article  CAS  PubMed  Google Scholar 

  • Kleindienst, N., Bohus, M., Ludäscher, P., Limberger, M. F., Kuenkele, K., Ebner-Priemer, U. W., et al. (2008). Motives for non-suicidal self-injury among women with borderline personality disorder. Journal of Nervous and Mental Disease, 196, 230–236.

    Article  PubMed  Google Scholar 

  • Klonsky, E. D. (2007). The functions of deliberate self-injury: A review of the evidence. Clinical Psychology Review, 27, 226–239.

    Article  PubMed  Google Scholar 

  • Kumra, S., Oberstar, J. V., Sikich, L., Findling, R. L., McClellan, J. M., Vinogradov, S., et al. (2008). Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophrenia Bulletin, 34, 60–71.

    Article  PubMed  Google Scholar 

  • Libal, G., & Plener, P. L. (2008). Pharmakologische Therapie des selbstverletzenden Verhaltens im Jugendalter. In R. Brunner & F. Resch (Eds.), Borderline-Störungen und selbstverletzendes Verhalten bei Jugendlichen (pp. 165–195). Göttingen: Vandenhoeck & Ruprecht.

    Google Scholar 

  • Libal, G., Plener, P. L., Ludolph, A. G., & Fegert, J. M. (2005). Ziprasidone as a weight-neutral treatment alternative in the treatment of self-injurious behavior in adolescent females. Child and Adolescent Psychopharmacology News, 10, 1–6.

    Article  Google Scholar 

  • Linehan, M. M., McDavid, J. D., Brown, M. Z., Sayrs, J. H., & Gallop, R. J. (2008). Olanzapine plus dialectical behaviour therapy for women with high irritability who meet criteria for borderline personality disorder: A double-blind, placebo-controlled pilot study. Journal of Clinical Psychiatry, 69, 999–1005.

    Article  CAS  PubMed  Google Scholar 

  • Markovitz, P. J., Calabrese, J. R., Schulz, C., & Meltzer, H. Y. (1991). Fluoxetine in the treatment of borderline and schizotypal personality disorders. American Journal of Psychiatry, 18, 1064–1067.

    Google Scholar 

  • Masters, K. J. (2008). Anti-suicidal and self-harm properties of lithium carbonate. CNS Spectrums, 13, 109–110.

    PubMed  Google Scholar 

  • McGee, M. D. (1997). Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone. Journal of Clinical Psychiatry, 58, 32–33.

    Article  CAS  PubMed  Google Scholar 

  • Mehler-Wex, C., Romanos, M., Kirchheiner, J., & Schulze, U. M. (2008). Atypical anti-psychotics in severe anorexia nervosa in children and adolescents—Review and case reports. European Eating Disorders Review, 16, 100–108.

    Article  PubMed  Google Scholar 

  • Mercer, D., Douglass, A. B., & Links, P. S. (2009). Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: Effectiveness for depression and anger symptoms. Journal of Personality Disorders, 23, 156–174.

    Article  PubMed  Google Scholar 

  • Nickel, M. K., Loew, T. H., & Pedrosa, G. F. (2007). Aripiprazole in treatment of borderline patients, part II: An 18-month follow-up. Psychopharmacology, 191, 1023–1026.

    Article  CAS  PubMed  Google Scholar 

  • Nickel, M. K., Muehlbacher, M., Nickel, K., Kettler, C., Gil, F. P., Bachler, E., et al. (2006). Aripiprazole in the treatment of patients with borderline personality disorder: A double-blind, placebo-controlled study. American Journal of Psychiatry, 163, 833–838.

    Article  PubMed  Google Scholar 

  • Nixon, M. K., Cloutier, P. F., & Aggarwal, S. (2002). Affect regulation and addictive aspects of repetitive self-injury in hospitalized adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1333–1341.

    Article  PubMed  Google Scholar 

  • Nose, M., Cipriani, A., Biancosino, B., Grassi, L., & Barbui, C. (2006). Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials. International Clinical Psychopharmacology, 21, 345–353.

    Article  PubMed  Google Scholar 

  • Osuch, E. A., & Payne, G. W. (2009). Neurobiological perspectives on self-injury. In M. K. Nixon & N. L. Heath (Eds.), Self-injury in youth (pp. 79–111). New York: Routledge.

    Google Scholar 

  • Owen, C., Rees, A. M., & Parker, G. (2008). The role of fatty acids in the development and treatment of mood disorders. Current Opinion in Psychiatry, 21, 19–24.

    Article  PubMed  Google Scholar 

  • Parikh, M. S., Kolevzon, A., & Hollander, E. (2008). Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology, 18, 157–178.

    Article  PubMed  Google Scholar 

  • Pies, R. W., & Popli, A. P. (1995). Self-injurious behavior: Pathophysiology and implications for treatment. Journal of Clinical Psychiatry, 56, 580–588.

    CAS  PubMed  Google Scholar 

  • Plener, P. L., Libal, G., Fegert, J. M., & Kölch, M. G. (2013). Psychopharmacological treatment of non-suicidal self-injury. Nervenheilkunde, 32, 38–41.

    Google Scholar 

  • Plener, P. L., Libal, G., & Nixon, M. K. (2009). Use of medication in the treatment of nonsuicidal self-injury in youth. In M. K. Nixon & N. L. Heath (Eds.), Self-injury in youth (pp. 275–309). New York: Routledge.

    Google Scholar 

  • Powers, P. S., Klabunde, M., & Kaye, W. (2012). Double-blind placebo-controlled trial of quetiapine in anorexia nervosa. European Eating Disorders Review, 20, 331–334.

    Article  PubMed  Google Scholar 

  • Roberts, N. (2003). Adolescent self-mutilatory behavior: Psychopharmacological treatment. Child and Adolescent Psychopharmacology News, 8, 10–12.

    Article  Google Scholar 

  • Roth, A. S., Ostroff, R. B., & Hoffman, E. R. (1996). Naltrexone as a treatment for repetitive self-injurious behaviour: An open-label trial. Journal of Clinical Psychiatry, 57, 233–237.

    CAS  PubMed  Google Scholar 

  • Rothschild, A. J., Shindul-Rothschild, J. A., Viguera, A., Murray, M., & Brewster, S. (2000). Comparison of the frequency of behavioural disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients. Journal of Clinical Psychopharmacology, 20, 7–11.

    Article  CAS  PubMed  Google Scholar 

  • Sandman, C. A. (1990/1991). The opiate hypothesis in autism and self-injury. Journal of Child and Adolescent Psychopharmacology, 1, 237–248.

    Article  Google Scholar 

  • Sandman, C. A. (2009). Psychopharmacologic treatment of nonsuicidal self-injury. In M. K. Nock (Ed.), Understanding nonsuicidal self-injury. Origins, assessment, and treatment (pp. 291–323). Washington, DC: American Psychological Association.

    Chapter  Google Scholar 

  • Sandman, C. A., Hetrick, W. P., Taylor, D. V., Barron, J. L., Touchette, P., Lott, I., et al. (1993). Naltrexone reduces self-injury and improves learning. Experimental and Clinical Psychopharmacology, 1, 242–258.

    Article  Google Scholar 

  • Scahill, L., & Koenig, K. (1999). Pharmacotherapy in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychiatric Nursing, 12, 41–43.

    Article  CAS  PubMed  Google Scholar 

  • Schulz, S. C., Zanarini, M. C., Bateman, A., Bohus, M., Detke, H. C., Trzaskoma, Q., et al. (2008). Olanzapine for the treatment of borderline personality disorder: Variable dose 12-week randomised double-blind placebo-controlled study. British Journal of Psychiatry, 193, 485–492.

    Article  PubMed  Google Scholar 

  • Sher, L., & Stanley, B. (2009). Biological models of nonsuicidal self-injury. In M. K. Nock (Ed.), Understanding nonsuicidal self-injury. Origins, assessment, and treatment (pp. 99–117). Washington, DC: American Psychological Association.

    Chapter  Google Scholar 

  • Simpson, E. B., Yen, S., Costello, E., Rosen, K., Begin, A., Pistorello, J., et al. (2004). Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry, 65, 379–385.

    Article  CAS  PubMed  Google Scholar 

  • Sonne, S., Rubey, R., Brady, K., Malcolm, R., & Morris, T. (1996). Naltrexone treatment of self-injurious thoughts and behaviours. Journal of Nervous and Mental Disease, 184, 192–195.

    Article  CAS  PubMed  Google Scholar 

  • Swenne, I., Rosling, A., Tengblad, S., & Vessby, B. (2011). Omega-3 polyunsaturated essential fatty acids are associated with depression in adolescents with eating disorders and weight loss. Acta Paediatrica, 100, 1610–1615.

    Article  CAS  PubMed  Google Scholar 

  • Symons, F. J., Thompson, A., & Rodriguez, M. C. (2004). Self-injurious behaviour and the efficacy of naltrexone treatment: A quantitative synthesis. Mental Retardation and Developmental Disabilities Research Reviews, 10, 193–200.

    Article  PubMed  Google Scholar 

  • Teicher, M. H., Glod, C. A., & Cole, J. O. (1993). Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety, 8, 186–212.

    Article  CAS  PubMed  Google Scholar 

  • Thompson, T., Hackenberg, T., Cerutti, D., Baker, D., & Axtell, S. (1994). Opioid antagonist effects on self-injury in adults with mental retardation: Response from and location as determinants of medication effects. American Journal of Mental Retardation, 99, 85–102.

    CAS  PubMed  Google Scholar 

  • Trunko, M. E., Schwartz, T. A., Duvvuri, V., & Kaye, W. H. (2011). Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: Case reports. International Journal of Eating Disorders, 44, 269–275.

    Article  PubMed  Google Scholar 

  • Verkes, R. J., Van der Mast, R. C., Hengeveld, M. W., Tuyl, J. P., Zwinderman, A. H., & Van Kempen, G. M. (1998). Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry, 155, 543–547.

    CAS  PubMed  Google Scholar 

  • Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. The Lancet, 36, 1341–1345.

    Article  Google Scholar 

  • Zanarini, M. C., & Frankenburg, F. R. (2003). Omega-3 fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. American Journal of Psychiatry, 160, 167–169.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany

    Paul L. Plener & Ulrike M. Schulze

Authors
  1. Paul L. Plener
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrike M. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul L. Plener .

Editor information

Editors and Affiliations

  1. Department of Psychology, KU Leuven, Leuven, Belgium

    Laurence Claes

  2. Department of Psychology, University of Wisconsin-Eau Claire, Eau Claire, Wisconsin, USA

    Jennifer J. Muehlenkamp

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Plener, P.L., Schulze, U.M. (2014). Pharmacological Treatment of Non-suicidal Self-injury and Eating Disorders. In: Claes, L., Muehlenkamp, J. (eds) Non-Suicidal Self-Injury in Eating Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40107-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40107-7_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40106-0

  • Online ISBN: 978-3-642-40107-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation